135 related articles for article (PubMed ID: 8721267)
1. [Systemic neoadjuvant chemotherapy in advanced head and neck tumors: a randomized study of the combination of 5-FU/carboplatin versus 5-FU/cisplatin].
Starr S
Strahlenther Onkol; 1996 Mar; 172(3):173-5. PubMed ID: 8721267
[No Abstract] [Full Text] [Related]
2. [The present situation of neoadjuvant therapy for head and neck carcinoma].
Rikimaru F; Tomita K
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.
Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY
Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck.
Prévost A; Mérol JC; Aimé P; Moutel K; Roger-Liautaud F; Nasca S; Legros M; Coninx P
Oncol Rep; 2005 Sep; 14(3):771-6. PubMed ID: 16077990
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with S-1 and carboplatin for head and neck cancers].
Watanabe A; Taniguchi M; Tsujie H
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():155-9. PubMed ID: 16897993
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
9. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
10. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy in the treatment of head and neck cancer.
Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
[No Abstract] [Full Text] [Related]
12. [Role of Chemotherapy in head and neck cancer].
Kohno N; Kitahara S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
[TBL] [Abstract][Full Text] [Related]
13. What is the optimal regimen of cisplatin plus 5-FU for head and neck cancer?
Chen MC
Oncology (Williston Park); 1990 Feb; 4(2):19. PubMed ID: 2143665
[No Abstract] [Full Text] [Related]
14. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
15. [Chemoradiotherapy for patients with advanced head and neck cancer].
Tsukuda M
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
Specenier PM; Vermorken JB
Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
Hussain M; Salwen W; Kucuk O; Ensley J
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R
Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]